Cargando…
Dapagliflozin rescues endoplasmic reticulum stress-mediated cell death
The new type 2 diabetes drug, dapagliflozin, reduces blood glucose levels and body weight by inhibiting sodium glucose transporter 2 (SGLT2) in proximal tubular cells. SGLT2 inhibitors might modulate glucose influx into renal tubular cells, thereby regulating the metabolic conditions that cause endo...
Autores principales: | Shibusawa, Ryo, Yamada, Eijiro, Okada, Shuichi, Nakajima, Yasuyo, Bastie, Claire C., Maeshima, Akito, Kaira, Kyoichi, Yamada, Masanobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614429/ https://www.ncbi.nlm.nih.gov/pubmed/31285506 http://dx.doi.org/10.1038/s41598-019-46402-6 |
Ejemplares similares
-
Fyn phosphorylates AMPK to inhibit AMPK activity and AMP-dependent activation of autophagy
por: Yamada, Eijiro, et al.
Publicado: (2016) -
Effect of carbohydrate counting using bolus calculators on glycemic control in type 1 diabetes patients during continuous subcutaneous insulin infusion
por: Yamada, Eijiro, et al.
Publicado: (2017) -
Fyn Phosphorylates Transglutaminase 2 (Tgm2) and Modulates Autophagy and p53 Expression in the Development of Diabetic Kidney Disease
por: Uehara, Ryota, et al.
Publicado: (2023) -
Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity
por: Okada, Junichi, et al.
Publicado: (2020) -
Casual C peptide index: Predicting the subsequent need for insulin therapy in outpatients with type 2 diabetes under primary care
por: Uehara, Ryota, et al.
Publicado: (2022)